http://www.unboundmedicine.com/medline/ebm/research/desvenlafaxineUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19919295/full_citation/Clinical_utility_of_desvenlafaxine_50_mg/d_for_treating_MDD:_a_review_of_two_randomized_placebo_controlled_trials_for_the_practicing_physician_Reddy S, Kane C, Pitrosky B, et al. 
Clinical utility of desvenlafaxine 50 mg/d for treating MDD: a review of two randomized placebo-controlled trials for the practicing physician. [JOURNAL ARTICLE]
Curr Med Res Opin 2009 Nov 17.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19906341/full_citation/Assessing_the_efficacy_of_desvenlafaxine_for_improving_functioning_and_well_being_outcome_measures_in_patients_with_major_depressive_disorder:_a_pooled_analysis_of_9_double_blind_placebo_controlled_8_week_clinical_trials_Soares CN, Kornstein SG, Thase ME, et al. 
Assessing the efficacy of desvenlafaxine for improving functioning and well-being outcome measures in patients with major depressive disorder: a pooled analysis of 9 double-blind, placebo-controlled, 8-week clinical trials. [Journal Article, Research Support, Non-U.S. Gov't]
J Clin Psychiatry 2009 Oct; 70(10):1365-71.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19902676/full_citation/[Non_hormonal_treatment_for_vasomotor_symptoms_during_menopause:_role_of_desvenlafaxine]Lilue M, Palacios S 
[Non-hormonal treatment for vasomotor symptoms during menopause: role of desvenlafaxine] [English Abstract, Journal Article]
Ginecol Obstet Mex 2009 Oct; 77(10):475-81.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19885969/full_citation/Desvenlafaxine:_application_withdrawal__Desvenlafaxine:_withdrawal_of_marketing_application_for_depression_also_Desvenlafaxine: application withdrawal. Desvenlafaxine: withdrawal of marketing application for depression also. [Journal Article]
Prescrire Int 2009 Oct; 18(103):197.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19857151/full_citation/Use_of_Antidepressants_for_Management_of_Hot_Flashes_Carroll DG, Kelley KW 
Use of Antidepressants for Management of Hot Flashes. [JOURNAL ARTICLE]
Pharmacotherapy 2009 Nov; 29(11):1357-1374.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19779354/full_citation/Discontinuation_symptoms_and_taper/poststudy_emergent_adverse_events_with_desvenlafaxine_treatment_for_major_depressive_disorder_Montgomery SA, Fava M, Padmanabhan SK, et al. 
Discontinuation symptoms and taper/poststudy-emergent adverse events with desvenlafaxine treatment for major depressive disorder. [JOURNAL ARTICLE]
Int Clin Psychopharmacol 2009 Sep 23.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19775194/full_citation/Undertreatment_of_menopausal_symptoms_and_novel_options_for_comprehensive_management_Lewis V 
Undertreatment of menopausal symptoms and novel options for comprehensive management. [JOURNAL ARTICLE]
Curr Med Res Opin 2009 Sep 23.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19752839/full_citation/Analysis_of_depressive_symptoms_in_patients_with_major_depressive_disorder_treated_with_desvenlafaxine_or_placebo_Kornstein SG, Fava M, Jiang Q, et al. 
Analysis of depressive symptoms in patients with major depressive disorder treated with desvenlafaxine or placebo. [Journal Article]
Psychopharmacol Bull 2009; 42(3):21-35.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19724771/full_citation/Antidepressant_prescribing_by_specialty_and_treatment_of_premenstrual_dysphoric_disorder_Cascade E, Kalali AH, Halbreich U 
Antidepressant prescribing by specialty and treatment of premenstrual dysphoric disorder. [Journal Article]
Psychiatry (Edgmont) 2008 Dec; 5(12):14-5.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19698901/full_citation/Desvenlafaxine_50_and_100_mg/d_in_the_treatment_of_major_depressive_disorder:_An_8_week_phase_III_multicenter_randomized_double_blind_placebo_controlled_parallel_group_trial_and_a_post_hoc_pooled_analysis_of_three_studies_Tourian KA, Padmanabhan SK, Groark J, et al. 
Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: An 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies. [Journal Article]
Clin Ther 2009 Jun; 31(6 Pt 2):1405-23.
Abstract | Full Citation